Research Update

Iodine Deficiency: The Silent Return of a Public Health Crisis

May 8, 2026 · 6 min read

Iodine deficiency was once the leading preventable cause of intellectual disability worldwide. The triumph of iodized salt programs from the 1920s onward is one of public health's greatest successes — it eliminated endemic goiter and cretinism from most of the developed world. The US declared the problem solved. But NHANES survey data from successive decades tells an unsettling story: median urinary iodine concentrations in US adults fell by more than 50% between the early 1970s and early 2000s, and multiple population groups are now classified as at-risk for mild-to-moderate deficiency. Iodine deficiency never actually left — it just became less visible.

The mechanisms driving this resurgence are behavioral and industrial, not natural. They are also, importantly, addressable — but only if people know the problem exists.

Why Iodine Status Has Declined

The shift is driven by three converging trends. First, the public health advice to reduce sodium intake has caused many people to reduce salt consumption — and with it, their primary iodine source in the American diet. Iodized salt provides roughly 45 mcg of iodine per gram. A person cutting from 3,400 mg/day to 2,300 mg/day of sodium (per American Heart Association guidelines) reduces their iodized salt intake substantially. The cardiovascular benefit of that reduction is real; the iodine consequence has been largely ignored in public guidance.

Second, the food industry and restaurant sector use non-iodized salt overwhelmingly. Approximately 70% of US sodium consumption comes from processed and restaurant foods — nearly all of which use non-iodized salt for cost and technical reasons. The public health iodine program effectively covers only the minority of sodium consumed at home from iodized table salt.

Third, the dairy industry's shift away from iodophor sanitizers (used to clean milking equipment) has reduced the iodine content of cow's milk, historically a significant dietary iodine source. Simultaneously, the rise of plant-based diets has replaced iodine-rich dairy with plant milks that contain essentially no iodine unless specifically fortified. A 2020 analysis found that soy, almond, oat, and rice milk contained negligible iodine compared to the 50–60 mcg per cup in cow's milk.

Who Is at Risk

The groups at highest risk are pregnant women, vegans and vegetarians, people avoiding dairy and salt, and those in regions with iodine-poor soils (parts of the Midwest and Mountain West). Pregnant women face the most severe consequences: iodine requirements increase by 50% during pregnancy (from 150 mcg to 220 mcg/day RDA), and iodine is essential for fetal thyroid hormone production, which regulates brain development. Even mild iodine deficiency during the first trimester — before the fetal thyroid is functional — is associated with measurable IQ reductions in the child.

NHANES data from 2001–2010 found that 35% of US women of childbearing age had urinary iodine concentrations below 100 mcg/L — the WHO threshold for adequacy. A study of Boston-area pregnant women found 56% classified as iodine-insufficient. Despite this, only 15–20% of prenatal vitamins sold in the US contain iodine (typically 150 mcg), and when they do, it is often in the less bioavailable potassium iodate form rather than potassium iodide.

The Upper Limit Problem

Iodine has a U-shaped risk curve. Both deficiency and excess cause thyroid dysfunction. The tolerable upper intake level (UL) for adults is 1,100 mcg/day, but even doses above 300–400 mcg/day can trigger autoimmune thyroiditis (Hashimoto's) flares in susceptible individuals. Supplement products marketed for thyroid support often contain 12,500 mcg or more of iodine — up to 83 times the RDA — posing genuine risk of iodine-induced hyperthyroidism or worsening autoimmune thyroid disease. The paradoxical Wolff-Chaikoff effect means that very high iodine intake can transiently suppress thyroid hormone synthesis, followed by rebound over- or under-production depending on thyroid autoimmunity status.

High-dose iodine supplementation (above the RDA) is not recommended for healthy adults without documented deficiency. Seaweed products, particularly kelp supplements, contain highly variable and often extreme iodine concentrations — a single kelp capsule may deliver 200–2,000 mcg. Routine kelp supplementation for iodine carries significant risk of thyroid disruption.

Practical Guidance

For most adults, ensuring iodized table salt is used at home and verifying that prenatal vitamins contain at least 150 mcg of potassium iodide covers iodine needs. Vegans should consider a specific iodine supplement of 150 mcg/day or ensure fortified plant milks (check labels — fortification is not universal). Pregnant women should specifically confirm their prenatal vitamin contains iodine. People with known thyroid conditions, particularly Hashimoto's or Graves' disease, should discuss iodine intake with their endocrinologist before supplementing, as both excess and deficiency can destabilize these conditions.

Sources

  1. Caldwell KL, Makhmudov A, Ely E, Jones RL, Wang RY. "Iodine status of the US population, National Health and Nutrition Examination Survey, 2005–2006 and 2007–2008." Thyroid, 2011;21(4):419–427. PMID: 21323596. DOI: 10.1089/thy.2010.0077.
  2. Hollowell JG, Staehling NW, Hannon WH, et al. "Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971–1974 and 1988–1994)." Journal of Clinical Endocrinology & Metabolism, 1998;83(10):3401–3408. PMID: 9768640. DOI: 10.1210/jcem.83.10.5168.
  3. Pearce EN, Andersson M, Zimmermann MB. "Global iodine nutrition: Where do we stand in 2013?" Thyroid, 2013;23(5):523–528. PMID: 23472655. DOI: 10.1089/thy.2013.0128.
  4. Bath SC, Hill S, Infante HG, Elahi S, Rayman MP. "Iodine concentration of milk-alternative drinks available in the UK in comparison with cows' milk." British Journal of Nutrition, 2017;118(7):525–532. PMID: 29017646. DOI: 10.1017/S0007114517002136.
  5. Bath SC, Steer CD, Golding J, Emmett P, Rayman MP. "Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children." Lancet, 2013;382(9889):331–337. PMID: 23706508. DOI: 10.1016/S0140-6736(13)60436-5.
  6. Leung AM, Pearce EN, Braverman LE. "Iodine content of prenatal multivitamins in the United States." New England Journal of Medicine, 2009;360(9):939–940. PMID: 19246369. DOI: 10.1056/NEJMc0807851.